ArticlePharmacology research & perspectives2016

Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 10A inhibitor, PDM-042 [(

Keita Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.